PSC Versus Beneficial Owner (UBO): Key Differences And When Both Apply

Person with Significant Control (PSC) An individual or registrable entity meeting UK ownership or control criteria that must be disclosed under the PSC regime.

PSC is a UK statutory construct; beneficial owner (or ultimate beneficial owner, UBO) terminology is used more broadly by international anti‑money laundering (AML) regimes. Both concepts aim to reveal who ultimately controls or benefits from a company, but they differ in legal tests, scope, and reporting mechanisms. This article explains the key differences and how organisations reconcile PSC and UBO obligations when they overlap.

Differences In Legal Tests And Thresholds

The PSC tests are specific statutory criteria set out in UK company law. They include ownership of shares above a percentage threshold, significant voting rights, board appointment rights, or exercise of significant influence. UBO definitions used in AML frameworks often look to any natural person who ultimately owns or controls a corporate entity through ownership, control, or other means, using slightly different thresholds and with an explicit focus on the risk of illicit finance. In practice, a PSC will often be a UBO and vice‑versa, but divergences occur with complex ownership structures, trusts, and nominee arrangements.

Scope And Reporting Channels

PSC information is recorded in corporate registers and reported to Companies House. UBO data is collected by regulated firms (banks, auditors, certain professional services) and reported internally as part of KYC and AML screening; regulators maintain records of reporting but there isn’t a single consolidated public UBO register equivalent to the PSC public register (though many jurisdictions now maintain beneficial‑ownership registries). The purposes diverge: PSC registers serve corporate transparency and company law; UBO data supports financial crime prevention and regulatory supervision.

How The Two Regimes Interact

When both regimes apply, companies and their commercial partners should align investigations. Start with the PSC statutory tests to identify named persons, then extend AML due diligence to capture any additional individuals who effectively control or benefit from the company but may fall outside PSC thresholds. For entities with trust interests, trustees or settlors may be UBOs without being PSCs, depending on control tests.

Cross‑Border And Practical Considerations

Global companies, including US firms operating in the UK, should map ownership structures against both PSC and UBO definitions. Differences in thresholds (for example, a jurisdiction using a >25% threshold versus another using >10%) can create compliance gaps. Use consistent internal procedures to capture ownership chains, require shareholder declarations where necessary, and reconcile registers during onboarding and periodic reviews.

Practical Steps To Reconcile Registers

• Map Ownership: Create an ownership diagram for each entity that traces through corporate layers and trusts to natural persons.
• Apply Tests: Run both the PSC statutory criteria and your AML/Ubo tests to the same ownership map to spot mismatches.
• Collect Evidence: Maintain documents supporting both PSC entries and UBO determinations (share ledgers, trust deeds, contracts).
• Coordinate Filing: Ensure PSC data is filed with Companies House and UBO data is available to regulated partners and internal compliance teams as required.

When To Seek Legal Or Compliance Advice

Complex group structures, cross‑jurisdictional trusts, nominee arrangements, and contested control claims warrant specialist advice. Legal counsel and AML specialists can interpret statutory tests, advise on disclosure obligations, and help design reconciled processes to satisfy both corporate‑law and AML expectations.

In short, the Person with Significant Control (PSC) framework and beneficial‑ownership/UBO rules share the objective of revealing who controls companies but differ in legal detail, scope, and reporting routes. Organisations should treat PSC and UBO checks as complementary: run both, reconcile results, and keep clear documentary proof for each determination.